EVOPLASTEC ApS: Financial statements 2023
CVR: 21273295
Source: annual report 2023, Danish Business Authority
01/10/2022 – 30/09/2023
EVOPLASTEC ApS (CVR 21273295) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 17,614 and a net result of DKK 1,539,275 compared with DKK 1,626,272 the year before. That is a decrease of 90.6% compared with the year before. Equity in the 2023 report amounted to DKK 29,207,997. The solvency ratio was 97.4%.
- Gross Profit
- DKK 17,614
- Profit/Loss
- DKK 1,539,275
- Equity
- DKK 29,207,997
- Total Assets
- DKK 29,982,834
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 18 t. | 1.5 mio. | 29.2 mio. | - |
| 2022 | - | 186 t. | 1.6 mio. | 27.7 mio. | - |
| 2021 | - | 176 t. | 1.8 mio. | 26.2 mio. | - |
| 2020 | - | 185 t. | 1.2 mio. | 24.5 mio. | - |
| 2019 | - | 154 t. | 1.1 mio. | 23.4 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
EVOPLASTEC ApS has published its annual report for 2022. Gross profit came to DKK 186,448, and the net result was DKK 1,626,272.
About EVOPLASTEC ApS
EVOPLASTEC ApS is a Danish company of the type Anpartsselskab based in Rønnede, founded in 1998. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Joachim Loock. The company is owned by Joachim Loock. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 81,021 and a net result of DKK -80,420 compared with DKK -34,248 the year before. Equity in the 2025 report amounted to DKK 28,965,329.